X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (78) 78
female (57) 57
tartrate-resistant acid phosphatase (57) 57
index medicus (53) 53
male (44) 44
acid phosphatase - blood (41) 41
isoenzymes - blood (41) 41
osteoporosis (39) 39
tracp 5b (36) 36
middle aged (35) 35
biomarkers - blood (34) 34
acid-phosphatase 5b (30) 30
aged (28) 28
resorption (28) 28
biochemical markers (27) 27
endocrinology & metabolism (26) 26
adult (24) 24
animals (23) 23
oncology (23) 23
tartrate-resistant acid phosphatase 5b (23) 23
turnover (23) 23
serum marker (22) 22
bones (21) 21
bone resorption (20) 20
bone neoplasms - secondary (19) 19
density (19) 19
immunoassay (19) 19
osteoclast (19) 19
orthopedics (18) 18
resistant acid-phosphatase (18) 18
disease (17) 17
isoform 5b (17) 17
acid phosphatase (16) 16
aged, 80 and over (16) 16
phosphatases (16) 16
alkaline phosphatase - blood (15) 15
bone density (15) 15
acid phosphatase - metabolism (14) 14
alkaline-phosphatase (14) 14
bone mineral density (14) 14
isoenzymes - metabolism (14) 14
metabolism (14) 14
mineral density (14) 14
phosphatase (14) 14
rats (14) 14
biomarkers (12) 12
biomarkers, tumor - blood (12) 12
bone and bones - metabolism (12) 12
bone density conservation agents - therapeutic use (12) 12
bone turnover (12) 12
bone-resorption (12) 12
collagen (12) 12
postmenopausal women (12) 12
adolescent (11) 11
analysis (11) 11
bone density - drug effects (11) 11
bone remodeling (11) 11
breast cancer (11) 11
expression (11) 11
health aspects (11) 11
medicine & public health (11) 11
metastasis (11) 11
osteocalcin (11) 11
serum (11) 11
zoledronic acid (11) 11
bone markers (10) 10
disease models, animal (10) 10
i collagen (10) 10
medical laboratory technology (10) 10
receptor activator (10) 10
rheumatology (10) 10
treatment outcome (10) 10
bone (9) 9
bone metastasis (9) 9
bone-mineral density (9) 9
cancer (9) 9
care and treatment (9) 9
hematology (9) 9
in-vitro (9) 9
medicine, research & experimental (9) 9
osteoclasts (9) 9
osteoclasts - metabolism (9) 9
rats, sprague-dawley (9) 9
sensitivity and specificity (9) 9
time factors (9) 9
bone neoplasms - enzymology (8) 8
bone turnover markers (8) 8
bone-specific alkaline phosphatase (8) 8
breast neoplasms - pathology (8) 8
breast-cancer (8) 8
case-control studies (8) 8
diagnosis (8) 8
enzymes (8) 8
kappa-b ligand (8) 8
osteoprotegerin (8) 8
physiological aspects (8) 8
prostate-cancer (8) 8
research (8) 8
rodents (8) 8
acid phosphatase tartrate resistant isoenzyme (7) 7
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


PLoS ONE, ISSN 1932-6203, 01/2016, Volume 11, Issue 1, p. e0147554
Journal Article
Journal Article
American Journal of Human Biology, ISSN 1042-0533, 05/2019, Volume 31, Issue 3, pp. e23240 - n/a
Journal Article
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, ISSN 0392-2936, 2011, Volume 32, Issue 6, pp. 615 - 618
Journal Article
Journal of Tokyo Women's Medical University, ISSN 0040-9022, 2011, Volume 81, Issue 6, pp. 397 - 402
Objective:Chronic kidney disease-mineral and bone disorder (CKD-MBD) is a regular complication of hemodialysis patients. On the other hand, with advances in... 
Journal Article
Journal of Bone and Mineral Research, ISSN 0884-0431, 03/2011, Volume 26, Issue 3, pp. 530 - 537
Denosumab, a fully human monoclonal antibody to RANKL, decreases bone remodeling, increases bone density, and reduces fracture risk. This study evaluates the... 
PROCOLLAGEN TYPE I N‐TERMINAL PROPEPTIDE (PINP) | DENOSUMAB | BONE ALKALINE PHOSPHTASE (BALP) | C‐TELOPEPTIDE OF TYPE I COLLAGEN (CTX) | TARTRATE‐RESISTANT ACID PHOSPHATASE (TRACP 5b) | OSTEOPOROSIS | BONE TURNOVER MARKERS | osteoporosis | Bone turnover markers | denosumab | tartrate-resistant acid phosphatase (TRACP 5b) | bone alkaline phosphtase (BALP) | C-telopeptide of type I collagen (CTX) | procollagen type I N-terminal propeptide (PINP) | BIOCHEMICAL MARKERS | VERTEBRAL FRACTURE | PHASE-2 | HEALTHY | TARTRATE-RESISTANT ACID PHOSPHATASE (TRACP 5b) | ALENDRONATE | TRIAL | WOMEN | C-TELOPEPTIDE OF TYPE I COLLAGEN (CTX) | MINERAL DENSITY | REDUCTION | ENDOCRINOLOGY & METABOLISM | BMD | PROCOLLAGEN TYPE I N-TERMINAL PROPEPTIDE (PINP) | Collagen Type I - blood | Isoenzymes - blood | Peptides - blood | Humans | Middle Aged | Tartrate-Resistant Acid Phosphatase | Antibodies, Monoclonal - therapeutic use | Reference Values | Bone Remodeling - drug effects | Dose-Response Relationship, Drug | Antibodies, Monoclonal, Humanized | RANK Ligand - pharmacology | Peptide Fragments - blood | Statistics, Nonparametric | Aged, 80 and over | Female | Acid Phosphatase - blood | RANK Ligand - therapeutic use | Alkaline Phosphatase - blood | Osteoporosis, Postmenopausal - enzymology | Antibodies, Monoclonal - pharmacology | Bone Density Conservation Agents - therapeutic use | Procollagen - blood | Biomarkers - blood | Denosumab | Osteoporosis, Postmenopausal - drug therapy<